In contrast, CCAO BAP1-Mut organoids showed only 3% pMLKL-positive cells, and this difference did not reach statistical significance, suggesting impaired necroptotic activation in the context of BAP1 mutation ( Figures 2 E and 2G).
← all excerpts
Functional characterization of BAP1 mutations in genome edited cholangiocarcinoma organoids: Role in cell death and drug responses.
1
—
—